Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaceutical Marketing Services Inc. (PMSI) was a leading provider of market research and data services to the pharmaceutical and healthcare industries. Founded in 1991 as a spin-off from Walsh International, the company specialized in tracking prescription data and providing physician-level marketing insights through its subsidiary, Scott-Levin. PMSI became a publicly traded entity on NASDAQ under the symbol PMKS before being acquired by IMS Health (now IQVIA) in 1999 for approximately $290 million. The acquisition significantly expanded IMS Health's capabilities in specialized pharmaceutical data and physician profiling, consolidating major sources of pharmaceutical market intelligence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaceutical Marketing Services.